Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Guardigli

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Circulation|January 23, 2003
Serum from patients with acute coronary syndromes displays a proapoptotic effect on human endothelial cells: a possible link to pan-coronary syndromesMarco Valgimigli, Laura Agnoletti, Salvatore Curello, et al.
Giornale Italiano Di Cardiologia (2006)|July 1, 2023
[Epicardial adipose tissue: a novel cardiovascular risk factor]Marco Micillo, Alberto Cossu, Graziella Pompei, et al.
Journal of Clinical Medicine|December 23, 2023
Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on RechallengeFederica Frascaro, Nicola Bianchi, Federico Sanguettoli, et al.
Cardiovascular Drugs and Therapy|July 2, 2004
High-dose bolus tirofiban and sirolimus eluting stent versus abiciximab and bare metal stent in acute myocardial infarction (STRATEGY) study--protocol design and demography of the first 100 patientsMarco Valgimigli, Gianfranco Percoco, Giordano Cicchitelli, et al.
Circulation|February 9, 2005
Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) studyMarco Valgimigli, Claudio Ceconi, Patrizia Malagutti, et al.
JAMA|May 5, 2005
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trialMarco Valgimigli, Gianfranco Percoco, Patrizia Malagutti, et al.
Molecular Medicine (Cambridge, Mass.)|May 23, 2007
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patientsDonato Gemmati, Federica Federici, Gianluca Campo, et al.
Journal of Clinical Medicine|February 15, 2022
Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary SyndromeRita Pavasini, Gioele Fabbri, Federico Marchini, et al.
The Lancet Regional Health. Europe|September 24, 2021
In- and out-of-hospital mortality for myocardial infarction during the first wave of the COVID-19 pandemic in Emilia-Romagna, Italy: A population-based observational studyGianluca Campo, Daniela Fortuna, Elena Berti, et al.
JACC. Clinical Electrophysiology|May 29, 2025
Left Ventricular Mechanical Insights Into Left Bundle Branch Pacing and Left Ventricular Septal PacingMatteo Bertini, Francesco Vitali, Michele Malagù, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Circulation|January 23, 2003
Serum from patients with acute coronary syndromes displays a proapoptotic effect on human endothelial cells: a possible link to pan-coronary syndromesMarco Valgimigli, Laura Agnoletti, Salvatore Curello, et al.
Giornale Italiano Di Cardiologia (2006)|July 1, 2023
[Epicardial adipose tissue: a novel cardiovascular risk factor]Marco Micillo, Alberto Cossu, Graziella Pompei, et al.
Journal of Clinical Medicine|December 23, 2023
Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on RechallengeFederica Frascaro, Nicola Bianchi, Federico Sanguettoli, et al.
Cardiovascular Drugs and Therapy|July 2, 2004
High-dose bolus tirofiban and sirolimus eluting stent versus abiciximab and bare metal stent in acute myocardial infarction (STRATEGY) study--protocol design and demography of the first 100 patientsMarco Valgimigli, Gianfranco Percoco, Giordano Cicchitelli, et al.
Circulation|February 9, 2005
Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) studyMarco Valgimigli, Claudio Ceconi, Patrizia Malagutti, et al.
JAMA|May 5, 2005
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trialMarco Valgimigli, Gianfranco Percoco, Patrizia Malagutti, et al.
Molecular Medicine (Cambridge, Mass.)|May 23, 2007
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patientsDonato Gemmati, Federica Federici, Gianluca Campo, et al.
Journal of Clinical Medicine|February 15, 2022
Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary SyndromeRita Pavasini, Gioele Fabbri, Federico Marchini, et al.
The Lancet Regional Health. Europe|September 24, 2021
In- and out-of-hospital mortality for myocardial infarction during the first wave of the COVID-19 pandemic in Emilia-Romagna, Italy: A population-based observational studyGianluca Campo, Daniela Fortuna, Elena Berti, et al.
JACC. Clinical Electrophysiology|May 29, 2025
Left Ventricular Mechanical Insights Into Left Bundle Branch Pacing and Left Ventricular Septal PacingMatteo Bertini, Francesco Vitali, Michele Malagù, et al.
Pageof 4